Categories
Research Insights
NIH: HEAL INITIATIVE: Development and validation of remote or patient wearable device derived objective biosignatures or functional assessments to monitor pain for use as endpoints in clinical trials (UG3/UH3 – Clinical Trial Optional)
This program promotes the discovery, development, and validation of real-world digital endpoints derived from data generated by existing remote or wearable devices. These endpoints will be used for monitoring the experience of pain, its progression, response to interventions, and impact on quality of life.
Amount: $1,510,000 (UG3 Phase); $6,795,000 (UH3 Phase)
Due Date: 01/30/2024